William D. Tap
Impact in
- Gastroenterology top 0.2%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.1%
- Sarcoma Diagnosis and Treatment
Papers in
-
- Sarcoma Diagnosis and Treatment 110
- Oncology 74
- Vascular Tumors and Angiosarcomas 26
- CAR-T cell therapy research 17
- Co-authors
- Cristina R. Antonescu (51 shared papers)Gary K. Schwartz (19 shared papers)Sandra P. D’ Angelo (35 shared papers)Samuel Singer (35 shared papers)Fritz C. Eilber (20 shared papers)Mrinal M. Gounder (21 shared papers)Mark Andrew Dickson (25 shared papers)Mary Louise Keohan (22 shared papers)
- Journals
- Clinical Cancer Research (28 papers)Annals of Oncology (17 papers)Journal of Clinical Oncology (15 papers)Cancer (9 papers)Modern Pathology (9 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
William D. Tap
253 papers receiving 18.6k citations
William D. Tap's Hit Papers
Peers
Comparison fields: 5 of 150
- Gastroenterology 1.5k
- Pulmonary and Respiratory Medicine 8.2k
- Oncology 6.8k
- Cancer Research 2.0k
- Rheumatology 2.0k
Countries citing papers authored by William D. Tap
This map shows the geographic impact of William D. Tap's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William D. Tap with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William D. Tap more than expected).
Fields of papers citing papers by William D. Tap
This network shows the impact of papers produced by William D. Tap. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William D. Tap. The network helps show where William D. Tap may publish in the future.
Co-authors
The 25 scholars most cited alongside William D. Tap, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 268 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor mutational load predicts survival after immunotherapy across multiple cancer types Hit paper breakdown → | 2019 | 3019 |
| 2 | Nivolumab with or without ipilimumab treatment for metastatic sarcoma (Alliance A091401): two open-label, non-comparative, randomised, phase 2 trials Hit paper breakdown → | 2018 | 603 |
| 3 | Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology Hit paper breakdown → | 2018 | 558 |
| 4 | Olaratumab and doxorubicin versus doxorubicin alone for treatment of soft-tissue sarcoma: an open-label phase 1b and randomised phase 2 trial Hit paper breakdown → | 2016 | 488 |
| 5 | PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors Hit paper breakdown → | 2014 | 479 |
| 6 | Structure-Guided Blockade of CSF1R Kinase in Tenosynovial Giant-Cell Tumor Hit paper breakdown → | 2015 | 467 |
| 7 | Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients Hit paper breakdown → | 2022 | 418 |
| 8 | Pexidartinib versus placebo for advanced tenosynovial giant cell tumour (ENLIVEN): a randomised phase 3 trial Hit paper breakdown → | 2019 | 367 |
| 9 | 2018 | 360 | |
| 10 | Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4 -Amplified Well-Differentiated or Dedifferentiated Liposarcoma Hit paper breakdown → | 2013 | 349 |
| 11 | Sorafenib for Advanced and Refractory Desmoid Tumors Hit paper breakdown → | 2018 | 333 |
| 12 | 2018 | 314 | |
| 13 | 2017 | 306 | |
| 14 | 2014 | 263 | |
| 15 | 2016 | 262 | |
| 16 | 2020 | 243 | |
| 17 | 2020 | 240 | |
| 18 | 2017 | 239 | |
| 19 | 2016 | 235 | |
| 20 | 2020 | 234 |
About William D. Tap
William D. Tap is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Rheumatology, Gastroenterology and Cancer Research, having authored 268 papers that have together received 18.9k indexed citations. Recurring topics across this work include Sarcoma Diagnosis and Treatment (110 papers), Gastrointestinal Tumor Research and Treatment (32 papers), Musculoskeletal synovial abnormalities and treatments (30 papers), Vascular Tumors and Angiosarcomas (26 papers), Cardiac tumors and thrombi (18 papers), CAR-T cell therapy research (17 papers), Cancer Genomics and Diagnostics (14 papers) and Bone Tumor Diagnosis and Treatments (13 papers). The work is most often cited by research in Gastroenterology (1.5k citations), Pulmonary and Respiratory Medicine (8.2k citations), Oncology (6.8k citations), Cancer Research (2.0k citations) and Rheumatology (2.0k citations). William D. Tap has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Cristina R. Antonescu, Gary K. Schwartz, Sandra P. D’ Angelo, Samuel Singer, Fritz C. Eilber, Mrinal M. Gounder, Mark Andrew Dickson, Mary Louise Keohan, Andrew Koff and Li‐Xuan Qin. Their work appears in journals such as Clinical Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Cancer and Modern Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.